Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clascoterone Cream in moderate to severe acne vulgaris
NCT07457294Phase 3Not yet recruiting
- Sponsor
- Zhejiang Sunshine Mandi Pharmaceutical Co., Ltd.
- Start
- May 2026
- Primary completion
- Aug 2028
- Modality
- Orthosteric Ligands
01
Overview
A Phase 3 trial of clascoterone in acne vulgaris, sponsored by Zhejiang Sunshine Mandi Pharmaceutical Co., Ltd.. Planned start May 2026; status: not yet recruiting.
02
Drugs
clascoterone
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on NCT07457294.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07457294.